Point72 Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Buy
1,012,126
+504,217
+99% +$2M ﹤0.01% 1915
2025
Q4
$1.78M Buy
+507,909
New +$1.74M ﹤0.01% 2548
2025
Q1
Sell
-1,569,823
Closed -$19.7M 2449
2024
Q4
$19.7M Buy
1,569,823
+1,521,727
+3,164% +$22.9M 0.04% 459
2024
Q3
$888K Buy
+48,096
New +$985K ﹤0.01% 1464
2018
Q1
Sell
-133,996
Closed -$1.4M 1089
2017
Q4
$1.4M Sell
133,996
-24,870
-16% -$247K 0.01% 774
2017
Q3
$1.13M Buy
+158,866
New +$726K 0.01% 729
2016
Q4
Sell
-220,000
Closed -$8.34M 814
2016
Q3
$8.34M Buy
220,000
+4,000
+2% +$126K 0.06% 313
2016
Q2
$6.43M Sell
216,000
-34,851
-14% -$1.23M 0.04% 378
2016
Q1
$7.42M Sell
250,851
-36,174
-13% -$1.09M 0.06% 347
2015
Q4
$13M Sell
287,025
-14,202
-5% -$619K 0.11% 222
2015
Q3
$11.3M Buy
+301,227
New +$13.8M 0.09% 279

Other funds holding RCKT